It is also unclear whether PTK7 expression has prognostic significance in adrenocortical carcinoma, but the expression of ENST00000489707.5, a preferred alternative splicing variant of PTK7, is an independent risk factor for disease-specific survival (DSS) and progression-free survival (PFS) (110). This evidence concerns the gene PTK7 and adrenal cortex carcinoma.